Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole IM Depot in Acute Schizophrenia
NCT03172871Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- May 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Holdings. Started May 2017; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03172871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172871.